283 related articles for article (PubMed ID: 9650749)
1. Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease.
Mattila PM; Röyttä M; Torikka H; Dickson DW; Rinne JO
Acta Neuropathol; 1998 Jun; 95(6):576-82. PubMed ID: 9650749
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.
Mattila PM; Rinne JO; Helenius H; Dickson DW; Röyttä M
Acta Neuropathol; 2000 Sep; 100(3):285-90. PubMed ID: 10965798
[TBL] [Abstract][Full Text] [Related]
3. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease.
Kövari E; Gold G; Herrmann FR; Canuto A; Hof PR; Bouras C; Giannakopoulos P
Acta Neuropathol; 2003 Jul; 106(1):83-8. PubMed ID: 12687392
[TBL] [Abstract][Full Text] [Related]
4. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
[TBL] [Abstract][Full Text] [Related]
5. Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem.
Yokota O; Tsuchiya K; Uchihara T; Ujike H; Terada S; Takahashi M; Kimura Y; Ishizu H; Akiyama H; Kuroda S
Neuropathology; 2007 Feb; 27(1):21-35. PubMed ID: 17319280
[TBL] [Abstract][Full Text] [Related]
6. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.
Bertrand E; Lechowicz W; Szpak GM; Lewandowska E; Dymecki J; Wierzba-Bobrowicz T
Folia Neuropathol; 2004; 42(3):141-50. PubMed ID: 15535032
[TBL] [Abstract][Full Text] [Related]
7. Cognitive status correlates with neuropathologic stage in Parkinson disease.
Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
[TBL] [Abstract][Full Text] [Related]
8. Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease.
Brown DF; Dababo MA; Bigio EH; Risser RC; Eagan KP; Hladik CL; White CL
J Neuropathol Exp Neurol; 1998 Jan; 57(1):39-46. PubMed ID: 9600196
[TBL] [Abstract][Full Text] [Related]
9. Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations.
Jacobson SA; Morshed T; Dugger BN; Beach TG; Hentz JG; Adler CH; Shill HA; Sabbagh MN; Belden CM; Sue LI; Caviness JN; Hu C;
Parkinsonism Relat Disord; 2014 Sep; 20(9):1009-14. PubMed ID: 25027359
[TBL] [Abstract][Full Text] [Related]
10. Neuropathology of dementia in a large cohort of patients with Parkinson's disease.
Horvath J; Herrmann FR; Burkhard PR; Bouras C; Kövari E
Parkinsonism Relat Disord; 2013 Oct; 19(10):864-8; discussion 864. PubMed ID: 23746454
[TBL] [Abstract][Full Text] [Related]
11. Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease.
Samuel W; Galasko D; Masliah E; Hansen LA
J Neuropathol Exp Neurol; 1996 Jan; 55(1):44-52. PubMed ID: 8558171
[TBL] [Abstract][Full Text] [Related]
12. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients.
Ince P; Irving D; MacArthur F; Perry RH
J Neurol Sci; 1991 Dec; 106(2):142-52. PubMed ID: 1802962
[TBL] [Abstract][Full Text] [Related]
13. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
[TBL] [Abstract][Full Text] [Related]
14. Choline acetytransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment.
Mattila PM; Röyttä M; Lönnberg P; Marjamäki P; Helenius H; Rinne JO
Acta Neuropathol; 2001 Aug; 102(2):160-6. PubMed ID: 11563631
[TBL] [Abstract][Full Text] [Related]
15. Lewy body cortical involvement may not always predict dementia in Parkinson's disease.
Colosimo C; Hughes AJ; Kilford L; Lees AJ
J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):852-6. PubMed ID: 12810766
[TBL] [Abstract][Full Text] [Related]
16. Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases.
Ruffmann C; Calboli FC; Bravi I; Gveric D; Curry LK; de Smith A; Pavlou S; Buxton JL; Blakemore AI; Takousis P; Molloy S; Piccini P; Dexter DT; Roncaroli F; Gentleman SM; Middleton LT
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):436-50. PubMed ID: 26527105
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease.
Wakabayashi K; Kakita A; Hayashi S; Okuizumi K; Onodera O; Tanaka H; Ishikawa A; Tsuji S; Takahashi H
Acta Neuropathol; 1998 May; 95(5):450-4. PubMed ID: 9600590
[TBL] [Abstract][Full Text] [Related]
18. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
Newell KL; Hyman BT; Growdon JH; Hedley-Whyte ET
J Neuropathol Exp Neurol; 1999 Nov; 58(11):1147-55. PubMed ID: 10560657
[TBL] [Abstract][Full Text] [Related]
19. Amyloid beta-peptide and the dementia of Parkinson's disease.
Jendroska K; Lees AJ; Poewe W; Daniel SE
Mov Disord; 1996 Nov; 11(6):647-53. PubMed ID: 8914090
[TBL] [Abstract][Full Text] [Related]
20. Dementia with Lewy bodies showing advanced Lewy pathology but minimal Alzheimer pathology--Lewy pathology causes neuronal loss inducing progressive dementia.
Uchikado H; Iseki E; Tsuchiya K; Togo T; Katsuse O; Uéda K; Kato M; Kosaka K
Clin Neuropathol; 2002; 21(6):269-77. PubMed ID: 12489676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
